Daiwa Securities Group Inc. reduced its position in shares of Express Scripts Holding Co. (NASDAQ:ESRX) by 5.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 50,145 shares of the company’s stock after selling 2,900 shares during the period. Daiwa Securities Group Inc.’s holdings in Express Scripts Holding were worth $3,537,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ESRX. Squarepoint Ops LLC purchased a new position in shares of Express Scripts Holding during the first quarter worth approximately $1,275,000. Summit Financial Wealth Advisors LLC purchased a new position in shares of Express Scripts Holding during the second quarter worth approximately $1,525,000. Kistler Tiffany Companies LLC increased its position in shares of Express Scripts Holding by 5.8% in the second quarter. Kistler Tiffany Companies LLC now owns 10,694 shares of the company’s stock worth $811,000 after buying an additional 590 shares during the period. First Financial Bank N.A. Trust Division purchased a new position in shares of Express Scripts Holding during the second quarter worth approximately $206,000. Finally, Stock Yards Bank & Trust Co. increased its position in shares of Express Scripts Holding by 0.5% in the second quarter. Stock Yards Bank & Trust Co. now owns 97,380 shares of the company’s stock worth $7,382,000 after buying an additional 506 shares during the period. 84.94% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded down 1.28% during midday trading on Wednesday, hitting $75.88. 5,569,834 shares of the company traded hands. The stock has a market capitalization of $46.79 billion, a PE ratio of 17.93 and a beta of 0.96. Express Scripts Holding Co. has a 52 week low of $64.46 and a 52 week high of $89.00. The stock has a 50 day moving average of $71.76 and a 200-day moving average of $73.84.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, October 25th. The company reported $1.74 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.74. The firm earned $25.41 billion during the quarter, compared to analyst estimates of $25.48 billion. Express Scripts Holding had a net margin of 2.70% and a return on equity of 24.99%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the business earned $1.45 earnings per share. Equities analysts forecast that Express Scripts Holding Co. will post $6.39 earnings per share for the current fiscal year.

WARNING: This article was first posted by Financial Market News and is the propert of of Financial Market News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright law. The legal version of this article can be accessed at http://www.financial-market-news.com/daiwa-securities-group-inc-has-3537000-stake-in-express-scripts-holding-co-esrx/1211135/.

A number of research analysts have recently commented on ESRX shares. Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Leerink Swann reissued a “market perform” rating and issued a $80.00 price objective on shares of Express Scripts Holding in a research report on Thursday, September 1st. Jefferies Group reissued a “buy” rating and issued a $88.00 price objective on shares of Express Scripts Holding in a research report on Monday, August 29th. Oppenheimer Holdings Inc. reissued a “market perform” rating on shares of Express Scripts Holding in a research report on Wednesday, November 2nd. Finally, Deutsche Bank AG raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating and lifted their price objective for the company from $69.00 to $70.00 in a research report on Thursday, November 3rd. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $80.78.

In other news, VP Christopher A. Mcginnis sold 1,785 shares of the firm’s stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $70.77, for a total value of $126,324.45. Following the completion of the transaction, the vice president now directly owns 4,955 shares in the company, valued at $350,665.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $70.40, for a total transaction of $847,334.40. Following the completion of the transaction, the director now owns 14,918 shares of the company’s stock, valued at $1,050,227.20. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co. (NASDAQ:ESRX).

Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.